A Clinical Study of 6MW3211 Injection in the Treatment of Relapsed/Refractory Lymphoma
Clinical trial NCT05446688 · UNKNOWN
Trial details
- NCT number
- NCT05446688
- Sponsor
- Mabwell (Shanghai) Bioscience Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-01
- Primary completion
- 2024-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.